Rockefeller Capital Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-3,500
| Closed | -$3K | – | 4206 |
|
|
2022
Q4 | $3K | Hold |
3,500
| – | – | ﹤0.01% | 3521 |
|
|
2022
Q3 | $5K | Hold |
3,500
| – | – | ﹤0.01% | 3370 |
|
|
2022
Q2 | $7K | Sell |
3,500
-2,000
| -36% | -$4K | ﹤0.01% | 3334 |
|
|
2022
Q1 | $12K | Hold |
5,500
| – | – | ﹤0.01% | 2974 |
|
|
2021
Q4 | $25K | Sell |
5,500
-2,000
| -27% | -$9.09K | ﹤0.01% | 2551 |
|
|
2021
Q3 | $57K | Hold |
7,500
| – | – | ﹤0.01% | 2081 |
|
|
2021
Q2 | $72K | Sell |
7,500
-1,200
| -14% | -$11.5K | ﹤0.01% | 1928 |
|
|
2021
Q1 | $71K | Buy |
8,700
+550
| +7% | +$4.49K | ﹤0.01% | 1756 |
|
|
2020
Q4 | $55K | Buy |
8,150
+3,350
| +70% | +$22.6K | ﹤0.01% | 1663 |
|
|
2020
Q3 | $53K | Buy |
4,800
+1,500
| +45% | +$16.6K | ﹤0.01% | 1490 |
|
|
2020
Q2 | $21K | Buy |
3,300
+1,000
| +43% | +$6.36K | ﹤0.01% | 1672 |
|
|
2020
Q1 | $4K | Hold |
2,300
| – | – | ﹤0.01% | 2050 |
|
|
2019
Q4 | $8K | Hold |
2,300
| – | – | ﹤0.01% | 1681 |
|
|
2019
Q3 | $5K | Buy |
+2,300
| New | +$5K | ﹤0.01% | 1655 |
|